Literature DB >> 21572565

Severe bacterial endophthalmitis: towards improving clinical outcomes.

Billy D Novosad1, Michelle C Callegan.   

Abstract

Endophthalmitis is an infection and inflammation of the interior of the eye that can result in significant vision loss. This infection occurs as a result of the seeding of organisms into the interior of the eye following surgery (postoperative), trauma (post-traumatic) or an infection in another site in the body (endogenous). The general rate of endophthalmitis has remained steady over the past several years. However, the increased use of intraocular injections to treat various degenerative and inflammatory ocular diseases, in addition to the already large and growing number of invasive ocular surgeries, may increase the opportunities in which organisms can gain access to the eye. In most cases of endophthalmitis, useful vision can be retained if proper treatment is instituted. However, in severe cases of bacterial endophthalmitis, blindness often occurs despite treatment. This article summarizes information on endophthalmitis epidemiology, treatment issues and current regimens, and recent experimental and clinical efforts to improve the outcome of severe and blinding forms of bacterial endophthalmitis.

Entities:  

Year:  2010        PMID: 21572565      PMCID: PMC3092298          DOI: 10.1586/eop.10.52

Source DB:  PubMed          Journal:  Expert Rev Ophthalmol        ISSN: 1746-9899


  99 in total

Review 1.  Endophthalmitis: the latest in current management.

Authors:  Robert G Josephberg
Journal:  Retina       Date:  2006 Jul-Aug       Impact factor: 4.256

Review 2.  Endogenous bacterial and fungal endophthalmitis.

Authors:  Stephen R Smith; Arnold J Kroll; Peter L Lou; Edward A Ryan
Journal:  Int Ophthalmol Clin       Date:  2007

3.  Postoperative vancomycin-resistant Enterococcus faecium endophthalmitis.

Authors:  Harshivinderjit S Bains; David V Weinberg; Robert S Feder; Gary A Noskin
Journal:  Arch Ophthalmol       Date:  2007-09

4.  Post-traumatic endophthalmitis: causative organisms and visual outcome.

Authors:  A M Abu el-Asrar; S A al-Amro; A A al-Mosallam; S al-Obeidan
Journal:  Eur J Ophthalmol       Date:  1999 Jan-Mar       Impact factor: 2.597

5.  Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics.

Authors:  Rookaya Mather; Lisa M Karenchak; Eric G Romanowski; Regis P Kowalski
Journal:  Am J Ophthalmol       Date:  2002-04       Impact factor: 5.258

6.  Nosocomial acute-onset postoperative endophthalmitis survey. A 10-year review of incidence and outcomes.

Authors:  T M Aaberg; H W Flynn; J Schiffman; J Newton
Journal:  Ophthalmology       Date:  1998-06       Impact factor: 12.079

7.  Culture-proven endogenous endophthalmitis: clinical features and visual acuity outcomes.

Authors:  Vivian Schiedler; Ingrid U Scott; Harry W Flynn; Janet L Davis; Matthew S Benz; Darlene Miller
Journal:  Am J Ophthalmol       Date:  2004-04       Impact factor: 5.258

8.  Topical prophylaxis with moxifloxacin prevents endophthalmitis in a rabbit model.

Authors:  Regis P Kowalski; Eric G Romanowski; Francis S Mah; Kathleen A Yates; Y Jerold Gordon
Journal:  Am J Ophthalmol       Date:  2004-07       Impact factor: 5.258

9.  Outpatient gatifloxacin therapy and dysglycemia in older adults.

Authors:  Laura Y Park-Wyllie; David N Juurlink; Alexander Kopp; Baiju R Shah; Therese A Stukel; Carmine Stumpo; Linda Dresser; Donald E Low; Muhammad M Mamdani
Journal:  N Engl J Med       Date:  2006-03-01       Impact factor: 91.245

10.  Endophthalmitis isolates and antibiotic sensitivities: a 6-year review of culture-proven cases.

Authors:  Matthew S Benz; Ingrid U Scott; Harry W Flynn; Nichard Unonius; Darlene Miller
Journal:  Am J Ophthalmol       Date:  2004-01       Impact factor: 5.258

View more
  14 in total

1.  Daptomycin versus vancomycin in a methicillin-resistant Staphylococcus aureus endophthalmitis rabbit model: bactericidal effect, safety, and ocular pharmacokinetics.

Authors:  Sophie Lefèvre; Maher Saleh; Luc Marcellin; Audrey Subilia; Tristan Bourcier; Gilles Prévost; François Jehl
Journal:  Antimicrob Agents Chemother       Date:  2012-02-27       Impact factor: 5.191

2.  Glycolytic inhibitor 2-deoxyglucose suppresses inflammatory response in innate immune cells and experimental staphylococcal endophthalmitis.

Authors:  Rebecca Francis; Pawan Kumar Singh; Sukhvinder Singh; Shailendra Giri; Ashok Kumar
Journal:  Exp Eye Res       Date:  2020-05-23       Impact factor: 3.467

3.  In Vivo Role of TLR2 and MyD88 Signaling in Eliciting Innate Immune Responses in Staphylococcal Endophthalmitis.

Authors:  Deepa Talreja; Pawan Kumar Singh; Ashok Kumar
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-02-12       Impact factor: 4.799

4.  National emergency department trends for endogenous endophthalmitis: an increasing public health challenge.

Authors:  Loka Thangamathesvaran; Joseph K Canner; Adrienne W Scott; Fasika A Woreta; Mark P Breazzano
Journal:  Eye (Lond)       Date:  2022-04-29       Impact factor: 3.775

5.  Increased resistance to Staphylococcus aureus endophthalmitis in BALB/c mice: Fas ligand is required for resolution of inflammation but not for bacterial clearance.

Authors:  Norito Sugi; Emily A Whiston; Bruce R Ksander; Meredith S Gregory
Journal:  Infect Immun       Date:  2013-04-08       Impact factor: 3.441

6.  Safety of besifloxacin ophthalmic suspension 0.6% as a prophylactic antibiotic following routine cataract surgery: results of a prospective, parallel-group, investigator-masked study.

Authors:  Ranjan Malhotra; Joseph Gira; Gregg J Berdy; Robert Brusatti
Journal:  Clin Ophthalmol       Date:  2012-06-05

7.  Clinical profile and outcome of endogenous endophthalmitis at a quaternary referral centre in south India.

Authors:  Gopal S Pillai; Kiran Krishnankutty Remadevi; V Anilkumar; Natasha Radhakrishnan; Rehna Rasheed; Greeshma C Ravindran
Journal:  Indian J Ophthalmol       Date:  2020-05       Impact factor: 1.848

8.  Intravitreal Injection and Quantitation of Infection Parameters in a Mouse Model of Bacterial Endophthalmitis.

Authors:  Md Huzzatul Mursalin; Erin Livingston; Phillip S Coburn; Frederick C Miller; Roger Astley; Michelle C Callegan
Journal:  J Vis Exp       Date:  2021-02-06       Impact factor: 1.355

Review 9.  A Systematic Review of Multi-decade Antibiotic Resistance Data for Ocular Bacterial Pathogens in the United States.

Authors:  Paulo J M Bispo; Daniel F Sahm; Penny A Asbell
Journal:  Ophthalmol Ther       Date:  2022-02-03

10.  Endogenous endophthalmitis: diagnosis, management, and prognosis.

Authors:  Mohammad Ali Sadiq; Muhammad Hassan; Aniruddha Agarwal; Salman Sarwar; Shafak Toufeeq; Mohamed K Soliman; Mostafa Hanout; Yasir Jamal Sepah; Diana V Do; Quan Dong Nguyen
Journal:  J Ophthalmic Inflamm Infect       Date:  2015-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.